347 related articles for article (PubMed ID: 18412155)
1. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
3. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma].
Xiang ZL; Zeng ZC; Tang ZY; Fan J; Sun HC; Wu WZ; Tan YS
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):344-9. PubMed ID: 20723431
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Tang ZY; Fan J; Sun HC; Tan YS
Mol Biol Rep; 2011 Jun; 38(5):3531-9. PubMed ID: 21104440
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy.
Sun HC; Zhuang PY; Qin LX; Ye QH; Wang L; Ren N; Zhang JB; Qian YB; Lu L; Fan J; Tang ZY
J Surg Oncol; 2007 Jul; 96(1):37-45. PubMed ID: 17345597
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
[TBL] [Abstract][Full Text] [Related]
8. The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.
Lee CW; Kuo WL; Yu MC; Chen TC; Tsai CN; Lee WC; Chen MF
World J Surg Oncol; 2013 Jun; 11(1):136. PubMed ID: 23758804
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
Zhou Q; Liang LJ; Peng BG; Zhen YY
Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
[TBL] [Abstract][Full Text] [Related]
10. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome.
Xiang Z; Zeng Z; Tang Z; Fan J; Sun H; Wu W; Tan Y
Cancer J; 2009; 15(6):519-25. PubMed ID: 20010172
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
[TBL] [Abstract][Full Text] [Related]
13. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.
Lu XY; Xi T; Lau WY; Dong H; Zhu Z; Shen F; Wu MC; Cong WM
Ann Surg Oncol; 2011 Aug; 18(8):2210-7. PubMed ID: 21308485
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
[TBL] [Abstract][Full Text] [Related]
16. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
Nishihara Y; Aishima S; Kuroda Y; Iguchi T; Taguchi K; Asayama Y; Taketomi A; Kinukawa N; Honda H; Tsuneyoshi M
J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
18. Step classification is useful for the determination of indications for systematized hepatectomy in hepatocellular carcinoma.
Ariizumi S; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
J Hepatobiliary Pancreat Surg; 2005; 12(5):371-7. PubMed ID: 16258805
[TBL] [Abstract][Full Text] [Related]
19. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma.
Ramacciato G; Mercantini P; Cautero N; Corigliano N; Di Benedetto F; Quintini C; Ercolani G; Varotti G; Ziparo V; Pinna AD
Ann Surg Oncol; 2005 Apr; 12(4):289-97. PubMed ID: 15827681
[TBL] [Abstract][Full Text] [Related]
20. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]